Pulse Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PLSE | ATRC | NAN.AX | MMSI | KMTS | SHREEPAC.BO | |
|---|---|---|---|---|---|---|
| Market cap | 4.07B | 3.33B | 882.54M | 5.43B | 1.82B | 635.39M |
| P/E (TTM) | — | 211.4 | 49.2 | 33.9 | — | 19.4 |
| Forward P/E | -48.8 | 154.0 | 56.7 | 19.4 | -14.8 | — |
| Price/book | 40.6 | 6.0 | 4.1 | 3.1 | 8.1 | 3.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +220.84% | +86.91% | −32.09% | −3.39% | +9.47% | −38.44% |
| Today | +9.31% | +8.48% | +1.03% | +7.69% | +5.14% | +0.18% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 20 min.
Latest news
All PLSE news ›The Electrophysiology Ablation Catheters Market Is Projected to Grow at a 17.4% CAGR Until 2030
The electrophysiology ablation catheters sector is experiencing rapid expansion driven by technological advancements and increasing demand for innovative cardiac treatment solutions This market is evolving swiftly shaped by both rising…
Pulse Biosciences, Inc (PLSE) – What Are Brokerages Thinking About This Stock?
Posted by Tristan Rich on Oct 31st, 2026 Read Our Latest Report on PLSE PLSE opened at $52.24 on Friday. The company has a fifty day moving average price of $51.08 and a two-hundred day moving average price of $31.29. Pulse Biosciences has…
NIH’s SPARC program spent a decade building the foundations of bioelectronic medicine
A new review details how the NIH Common Fund's SPARC initiative invested hundreds of millions of dollars over ten years to map peripheral nerves, build neuromodulation technologies, and share the results openly. Subject of Research:…
ReGen Medical’s Focused Energy Wave Technology Sets New Benchmark in Shockwave Therapy Precision
RCT’s focused-energy approach delivers therapeutic results in 3-5 sessions, now available at the Center for New Medicine in Irvine, California IRVINE, CA, UNITED STATES, October 23, 2026 /EINPresswire.com/ — ReGen Medical Network Teams…
Review Highlights MXenes as Conductive Scaffolds for Next-Generation Cardiac Patches
A new review in Annals of Biomedical Engineering examines how conductive two-dimensional MXene nanomaterials could advance cardiac patch design for restoring electrical and mechanical function after myocardial infarction.
Dual-Tagged Nanovesibles Hitch a Ride Across Heart Capillaries to Deliver a One-Two Punch Against Reperfusion Injury
Researchers engineered small extracellular vesicles with two targeting tags that exploit the heart's fatty acid transport machinery, improving delivery of edaravone and PKA-silencing RNA and reducing cardiac injury in mouse models of…
Weekly Investment Analysts’ Ratings Changes for Pulse Biosciences (PLSE)
A number of research firms have changed their ratings and price targets for Pulse Biosciences (NASDAQ: PLSE): 10/15/2026 – Pulse Biosciences had its “sell (d-)” rating reaffirmed by Weiss Ratings. 10/13/2026 – Pulse Biosciences was given a…
Varex Imaging (NASDAQ:VREX) vs. Pulse Biosciences (NASDAQ:PLSE) Head to Head Review
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) and Varex Imaging (NASDAQ:VREX – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their…
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
BioSpace Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center Collaboration adds the nPulse™ Vybrance™ System to patient care at the Hospital for Endocrine Surg
Pulse Biosciences signs Clayman Thyroid Center deal
The Clayman Thyroid Center is the only Tampa Bay Area site offering nPulse technology for symptomatic benign thyroid nodules. Pulse Biosciences, Inc. (PLSE) announced agreements with the Clayman Thyroid Center at the Hospital for Endocrine…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com15
- stocktitan.net3
- defenseworld.net2
- biospace.com1
- streetinsider.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.